It was found that human ALS patients have an increased prevalence of harmful gain-of-function SARM1 mutations, which can exert many detrimental effects, the most notable being decreased NAD+ levels and increased susceptibility to oxidative stress in neurons [87]. This evidence concerns the gene SARM1 and amyotrophic lateral sclerosis.